Centessa Pharmaceuticals (CNTA) Other Gross PP&E Adjustments (2022 - 2025)
Centessa Pharmaceuticals (CNTA) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with -$9.6 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments rose 15.07% to -$9.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.6 million through Dec 2025, up 15.07% year-over-year, with the annual reading at -$9.6 million for FY2025, 15.07% up from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 was -$9.6 million at Centessa Pharmaceuticals, up from -$9.7 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$1.3 million in Q2 2022, with the low at -$13.9 million in Q1 2023.
- Average Other Gross PP&E Adjustments over 4 years is -$9.0 million, with a median of -$10.8 million recorded in 2025.
- The sharpest move saw Other Gross PP&E Adjustments plummeted 877.34% in 2023, then grew 15.96% in 2024.
- Over 4 years, Other Gross PP&E Adjustments stood at -$2.8 million in 2022, then tumbled by 304.54% to -$11.5 million in 2023, then rose by 1.96% to -$11.3 million in 2024, then rose by 15.07% to -$9.6 million in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$9.6 million, -$9.7 million, and -$10.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.